MAIA Biotechnology, Inc. (MAIA) Financials

MAIA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 35.3 million 7.6 million
Dec. 31, 2025 9.7 billion 7.3 billion
Sept. 30, 2025 11.8 million 11.7 million
June 30, 2025 11.0 million 7.2 million

MAIA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -5.3 million 650024
Dec. 31, 2025 -7.0 million 810796
Sept. 30, 2025 -3.5 million 646900
June 30, 2025 -4.1 million 802484

MAIA Net Income

No data available :(

MAIA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 34.4 million - -
Dec. 31, 2025 8.7 billion - -
Sept. 30, 2025 10.9 million - -
June 30, 2025 10.1 million - -

MAIA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 45.2 million
Dec. 31, 2025 32.1 million
Sept. 30, 2025 33.2 million
June 30, 2025 30.3 million

MAIA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2 3.5 million 3.4 million -
Dec. 31, 2025 4 1.9 million 2.4 million -
Sept. 30, 2025 - 6.4 million 3.0 million -
June 30, 2025 4 3.1 million 2.1 million -

MAIA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

MAIA

Price: $1.30

52 week price:
0.87
3.19

Earnings Per Share: -0.68 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Market Capitalization: 82.7 million

Links: